Pulmonx shares soar 118% in trading debut

Shares of Pulmonx, a maker of treatments for lung diseases including emphysema, rose 118% in their trading debut Thursday, after the company’s initial public offering priced above range. The deal priced at $19 a share, abo…

Source link

You May Also Like

Kings probe ‘racial bias’ claims after rapper E-40 ejected

The Sacramento Kings are investigating allegations from a Bay Area hip-hop star…

Bill Madden: Veterans committee can take a stand for character in Hall of Fame vote

Just when we thought we’d said goodbye to Barry Bonds and Roger…

San Francisco sees record rain as flooding shuts down highway

San Francisco has seen one of its wettest days on record, as…

What is a suspected Chinese spy balloon doing above the US? | CNN

Seoul, South Korea CNN  —  News that the Pentagon is monitoring a…